July 22nd, 2020
A versatile vessel for next-gen therapeutics
Harvard’s ARMMs technology to be commercialized by Vesigen Therapeutics for targeted intracellular delivery of large-molecule drugs
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Startups
April 9th, 2020
Injections to become pills, in vision of Harvard-launched startup
New formulations enable oral delivery of therapeutics traditionally delivered intravenously
April 2nd, 2020
Nanoneedle technology licensed for early disease detection, biomarker discovery, and more
Startup NanoMosaic to commercialize high-sensitivity tool for protein detection and quantification
April 1st, 2020
From the lab to COVID front lines
Technology developed at Harvard provides early boost to Mass. COVID testing
February 6th, 2020
Rejuvenate Bio launches to help dogs live longer, healthier lives
Combination gene therapy developed at Wyss Institute and Harvard Medical School treats four age-related conditions
